The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Activation of Aldehyde Dehydrogenase-2 Reduces Ischemic Damage to the Heart
Open accessAbstract
There is substantial interest in the development of drugs that limit the extent of ischemia-induced cardiac damage caused by myocardial infarction or by certain surgical procedures. Here, using an unbiased proteomic search, we identified mitochondrial aldehyde dehydrogenase 2 (ALDH2) as an enzyme whose activation correlates with reduced ischemic heart damage in rodent models. A high-throughput screen yielded a small-molecule activator of ALDH2 (Alda-1) that, when administered to rats before an ischemic event, reduced infarct size by 60%, most likely through its inhibitory effect on the formation of cytotoxic aldehydes. In vitro, Alda-1 was a particularly effective activator of ALDH2*2, an inactive mutant form of the enzyme that is found in 40% of East Asian populations. Thus, pharmacologic enhancement of ALDH2 activity may be useful for patients with wild-type or mutant ALDH2 who are subjected to cardiac ischemia, such as during coronary bypass surgery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gray, M. O., Karliner, J. S., & Mochly-Rosen, D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.30945 · Cited by 390
Self-citationDorn, G. W., Souroujon, M. C., Liron, T., Chen, C.-H., Gray, M. O., Zhou, H. Z., Csukai, M., Wu, G., Lorenz, J. N., & Mochly-Rosen, D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12798 · Cited by 359
Self-citationSignaling pathways in ischemic preconditioning
Downey, J. M., Davis, A. M., & Cohen, M. V. (2007) · Heart Failure Reviews · doi:10.1007/s10741-007-9025-2 · Cited by 319
Cardiac reperfusion injury: Aging, lipid peroxidation, and mitochondrial dysfunction
Lucas, D. T., & Szweda, L. I. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.510 · Cited by 254
An essential role for mitochondrial aldehyde dehydrogenase in nitroglycerin bioactivation
Chen, Z., Foster, M. W., Zhang, J., Mao, L., Rockman, H. A., Kawamoto, T., Kitagawa, K., Nakayama, K. I., Hess, D. T., & Stamler, J. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503723102 · Cited by 231
Preconditioning: a paradigm shift in the biology of myocardial ischemia
Bolli, R. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00712.2006 · Cited by 201
Cloning of cDNAs for human aldehyde dehydrogenases 1 and 2.
Hsu, L. C., Tani, K., Fujiyoshi, T., Kurachi, K., & Yoshida, A. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.11.3771 · Cited by 194
Formation of 4-hydroxy-2-nonenal-modified proteins in ischemic rat heart
Eaton, P., Li, J., Hearse, D. J., & Shattock, M. J. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.276.3.h935 · Cited by 167
Nakano, A., Cohen, M. V., & Downey, J. M. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00058-9 · Cited by 164
Jabůrek, M., Costa, A. D. T., Burton, J. R., Costa, C. L., & Garlid, K. (2006) · Circulation Research · doi:10.1161/01.res.0000245106.80628.d3 · Cited by 147
Cited by
Ischemia and reperfusion—from mechanism to translation
Eltzschig, H. K., & Eckle, T. (2011) · Nature Medicine · doi:10.1038/nm.2507 · Cited by 3,382
Iorga, A., Cunningham, C. M., Moazeni, S., Ruffenach, G., Umar, S., & Eghbali, M. (2017) · Biology of Sex Differences · doi:10.1186/s13293-017-0152-8 · Cited by 914
Kalogeris, T., Bao, Y., & Korthuis, R. J. (2014) · Redox Biology · doi:10.1016/j.redox.2014.05.006 · Cited by 716
Targeting Aldehyde Dehydrogenase 2: New Therapeutic Opportunities
Chen, C.-H., Ferreira, J. C. B., Gross, E. R., & Mochly-Rosen, D. (2014) · Physiological Reviews · doi:10.1152/physrev.00017.2013 · Cited by 614
Self-citationProtein kinase C, an elusive therapeutic target?
Mochly-Rosen, D., Das, K., & Grimes, K. V. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3871 · Cited by 563
Self-citationFancd2 counteracts the toxic effects of naturally produced aldehydes in mice
Langevin, F., Crossan, G. P., Rosado, I. V., Arends, M. J., & Patel, K. J. (2011) · Nature · doi:10.1038/nature10192 · Cited by 500
Figueira, T. R., Barros, M. H., Camargo, A. A., Castilho, R. F., Ferreira, J. C. B., Kowaltowski, A. J., Sluse, F. E., Souza-Pinto, N. C., & Vercesi, A. E. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4729 · Cited by 419
Ischemia/Reperfusion Injury Revisited: An Overview of the Latest Pharmacological Strategies
Soares, R. O. S., Losada, D. M., Jordani, M. C., Évora, P., & Castro-e-Silva, O. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205034 · Cited by 408
Rungratanawanich, W., Qu, Y., Wang, X., Essa, M. M., & Song, B.-J. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00561-7 · Cited by 411
The role of the mitochondrial permeability transition pore in heart disease
Halestrap, A. P., & Pasdois, P. (2009) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2008.12.017 · Cited by 362
Metabolic effects of furaldehydes and impacts on biotechnological processes
Almeida, J. R. M., Bertilsson, M., Gorwa-Grauslund, M. F., Gorsich, S., & Lidén, G. (2009) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-009-1875-1 · Cited by 342
Ma, H., Guo, R., Yu, L., Zhang, Y., & Ren, J. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehq253 · Cited by 335
Novel therapeutic strategies targeting fibroblasts and fibrosis in heart disease
Gourdie, R. G., Dimmeler, S., & Kohl, P. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.89 · Cited by 332
Impaired dopamine metabolism in Parkinson’s disease pathogenesis
Masato, A., Plotegher, N., Boassa, D., & Bubacco, L. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0332-6 · Cited by 328
Lagranha, C. J., Deschamps, A., Aponte, A., Steenbergen, C., & Murphy, E. (2010) · Circulation Research · doi:10.1161/circresaha.109.213645 · Cited by 326
The SGLT2 inhibitor empagliflozin improves the primary diabetic complications in ZDF rats
Steven, S., Oelze, M., Hanf, A., Kröller-Schön, S., Kashani, F., Roohani, S., Welschof, P., Kopp, M., Gödtel-Armbrust, U., Xia, N., et al. (2017) · Redox Biology · doi:10.1016/j.redox.2017.06.009 · Cited by 298
Oelze, M., Kröller-Schön, S., Welschof, P., Jansen, T., Hausding, M., Mikhed, Y., Stamm, P., Mader, M., Zinßius, E., Agdauletova, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112394 · Cited by 293
Refined Geographic Distribution of the Oriental ALDH2*504Lys (nee 487Lys) Variant
Li, H., Borinskaya, S., Yoshimura, K., Kal’ina, N., Marusin, A., Stepanov, V. A., Qin, Z., Khaliq, S., Lee, M., Yang, Y., et al. (2009) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2009.00517.x · Cited by 285
Hill, B. G., Dranka, B. P., Zou, L., Chatham, J. C., & Darley-Usmar, V. M. (2009) · Biochemical Journal · doi:10.1042/bj20090934 · Cited by 284
Mitochondria as a Drug Target in Ischemic Heart Disease and Cardiomyopathy
Walters, A. M., Porter, G. A., & Brookes, P. S. (2012) · Circulation Research · doi:10.1161/circresaha.112.265660 · Cited by 271
Daiber, A., Di Lisa, F., Oelze, M., Kröller‐Schön, S., Steven, S., Schulz, E., & Münzel, T. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13403 · Cited by 269
Monoamine oxidases as sources of oxidants in the heart
Kaludercic, N., Mialet-Perez, J., Paolocci, N., Parini, A., & Di Lisa, F. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.12.032 · Cited by 253
Takeuchi, F., Isono, M., Nabika, T., Katsuya, T., Sugiyama, T., Yamaguchi, S., Kobayashi, S., Ogihara, T., Yamori, Y., Fujioka, A., et al. (2011) · Circulation Journal · doi:10.1253/circj.cj-10-0774 · Cited by 146
Lysine deacetylation in ischaemic preconditioning: the role of SIRT1
Nadtochiy, S. M., Redman, E., Rahman, I., & Brookes, P. S. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvq287 · Cited by 130
Song, B.-J., Akbar, M., Abdelmegeed, M. A., Byun, K., Lee, B., Yoon, S. K., & Hardwick, J. P. (2014) · Redox Biology · doi:10.1016/j.redox.2014.10.004 · Cited by 123
“These results are consistent with the cardioprotective role of ALDH2 which can be activated by small molecule activators [42,187] or over-expression by genetic modulation [188,189].”
ResultA comparison of organic and inorganic nitrates/nitrites
Omar, S. A., Artime, E., & Webb, A. J. (2012) · Nitric Oxide · doi:10.1016/j.niox.2012.03.008 · Cited by 106
Ji, W., Wei, S., Hao, P., Xing, J., Yuan, Q., Wang, J., Xu, F., & Chen, Y. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00101 · Cited by 106
Knorr, M., Hausding, M., Kröller-Schuhmacher, S., Steven, S., Oelze, M., Heeren, T., Scholz, A., Gori, T., Wenzel, P., Schulz, E., et al. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.232058 · Cited by 100
Post-translational modifications of mitochondrial aldehyde dehydrogenase and biomedical implications
Song, B.-J., Abdelmegeed, M. A., Yoo, S.-H., Kim, B.-J., Jo, S. A., Jo, I., & Moon, K.-H. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.05.013 · Cited by 73
Nuclear-encoded mitochondrial proteins and their role in cardioprotection
Boengler, K., Heusch, G., & Schulz, R. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.01.009 · Cited by 68
Song, B.-J., Abdelmegeed, M. A., Henderson, L. E., Yoo, S.-H., Wan, J., Purohit, V., Hardwick, J. P., & Moon, K.-H. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/781050 · Cited by 67
Moon, K.-H., Lee, Y.-M., & Song, B.-J. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.11.008 · Cited by 37
Metadata
- Authors
- Chen, C.-H., Budas, G. R., Churchill, E. N., Disatnik, M.-H., Hurley, T. D., & Mochly-Rosen, D.
- Venue
- Science
- Published
- 2008-09-12
- Volume
- 321
- Issue
- 5895
- Pages
- 1493-1495
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2057099146
- Cited by
- 767
- References
- 19
- FWCI
- 29.07
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.